SPONSOR

Icahn School of Medicine at Mount Sinai

Total Trials

Recruiting

Phases

Phase 4, EARLY_Phase 1, Phase 2, Phase 1, Phase 2

Conditions studied: Point of Care STI Testing Crohns Disease Pregnancy Inflammatory Bowel Disease Cocaine Use Disorder Cocaine Dependence Substance Use Disorder (SUD)Hepatocellular Carcinoma Pleuritis, Non-specific HPV-related Lower Genital Tract Neoplasias

Icahn School of Medicine at Mount Sinai is a clinical research sponsor with 29 registered studies on ClinicalTrials.gov, of which 29 are actively recruiting participants. Research covers conditions including Point of Care STI Testing, Crohns Disease, Pregnancy, Inflammatory Bowel Disease.

The trial portfolio spans Phase 4, EARLY_Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Icahn School of Medicine at Mount Sinai

How many clinical trials has Icahn School of Medicine at Mount Sinai sponsored?

ClinicalMetric currently tracks 29 clinical trials sponsored by Icahn School of Medicine at Mount Sinai, of which 29 are actively recruiting participants. These trials cover conditions including Point of Care STI Testing, Crohns Disease, Pregnancy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Icahn School of Medicine at Mount Sinai research focus on?

Icahn School of Medicine at Mount Sinai clinical trials span Point of Care STI Testing, Crohns Disease, Pregnancy, Inflammatory Bowel Disease, Cocaine Use Disorder, and additional conditions. The research pipeline includes Phase 4, EARLY_Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Icahn School of Medicine at Mount Sinai clinical trial?

To participate in a Icahn School of Medicine at Mount Sinai trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Icahn School of Medicine at Mount Sinai trials with current recruitment status updated daily.

Icahn School of Medicine at Mount Sinai

Frequently Asked Questions — Icahn School of Medicine at Mount Sinai

Clinical Trials by Icahn School of Medicine at Mount Sinai

Point of Care STI Testing

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis

Screening Women With Prior HPV for Anal Neoplasia

Multifaceted Intervention to Restore Resilience and Overcome Risk

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Validating CGM for GDM

Deucravacitinib in the Treatment of Cicatricial Alopecias

Metabolic Diet for Relapse Prevention in Anorexia Nervosa

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

CTSN Embolic Protection Trial

The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Tract Closure in PCNL

Interoceptive Exposure for Adolescents With Low Weight Eating Disorders

Memory Support System for Older Chinese Americans With Mild Cognitive Impairment

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

DevRobust Treatment for Mal de Débarquement Syndrome

Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder

Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)

Study of Cannabidiol and Neuroimaging on Stress

CaOx Stone Prevention

Neurofeedback During Eating for Bulimia Nervosa

A Study of the MIND Diet for Persons With Multiple Sclerosis

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery

Paired Non-invasive VNS in Adolescent Cerebral Palsy Rehabilitation